Ranolazine

Chronic Angina Treatment

Ranolazine is primarily used to treat chronic angina. This condition involves recurring chest pain or pressure that occurs when the heart muscle does not receive enough oxygen-rich blood. It is typically prescribed for patients who continue to experience symptoms despite taking other heart medications.

Long-Term Management

This medication is intended for the long-term prevention and management of chest pain. It helps improve the heart's ability to function during physical activity and may reduce the frequency of angina attacks over time. It is often used when other first-line treatments have not provided sufficient relief.

Use with Other Medications

Ranolazine is frequently used as an add-on therapy alongside other cardiovascular drugs. It can be safely taken with several classes of medications, including:

• Beta-blockers
• Nitrates
• Calcium channel blockers
• Anti-platelet medications
• Lipid-lowering therapies (such as statins)
• ACE inhibitors
• Angiotensin receptor blockers

Important Limitations

It is important to note that ranolazine is not a rescue medication. It will not stop a sudden (acute) attack of chest pain once it has started. For the immediate relief of sudden angina, a different type of fast-acting medication, such as sublingual nitroglycerin, is required.

Mechanism of Action

The exact way ranolazine works to treat chronic chest pain (angina) is not completely understood. However, it is believed to work by affecting the flow of sodium and calcium in the heart cells.

Improving Heart Function

In people with certain heart conditions, sodium channels in the heart muscle may stay open longer than they should. This causes an excess of sodium to enter the cells, which in turn leads to a buildup of calcium. Too much calcium can prevent the heart muscle from relaxing fully between beats, making it harder for blood to flow through the heart's vessels.

Ranolazine is thought to help by:

• Blocking the late inward sodium current in heart cells.
• Reducing the buildup of calcium in the heart muscle.
• Helping the heart muscle relax more effectively.
• Improving blood flow to the heart.

Differences from Other Medications

Most other medications used for chest pain work by slowing the heart rate or lowering blood pressure to reduce the heart's workload. Ranolazine is unique because it provides relief from chronic angina symptoms without causing significant changes to a person's heart rate or blood pressure levels.

Common Side Effects

Some people may experience mild side effects while taking ranolazine. These often include:

• Dizziness
• Headache
• Constipation
• Nausea
• Feeling weak

Serious Side Effects

While less common, some side effects can be serious. Seek medical attention right away if you experience:

• Fainting or severe lightheadedness
• Fast, pounding, or irregular heartbeat
• Shortness of breath
• Swelling in the feet or lower legs
• Blood in the urine or changes in urination frequency
• Tremors or shaking

A serious allergic reaction to this drug is rare. However, get medical help immediately if you notice symptoms such as a severe rash, swelling (especially of the face, tongue, or throat), or trouble breathing.

Heart Rhythm Changes

Ranolazine can prolong the QT interval, which is a measure of the heart's electrical cycle. This effect increases with higher concentrations of the drug. Caution is advised for individuals with a personal or family history of long QT syndrome or those taking other medications known to prolong the QT interval.

Kidney Function

Acute kidney failure has been reported in patients with severe kidney impairment who take ranolazine. Healthcare providers typically monitor kidney function regularly in patients with moderate to severe renal issues. If a significant decrease in kidney function occurs, the medication may need to be discontinued.

Liver Disease

This medication is contraindicated in patients with liver cirrhosis. The body's ability to process ranolazine is significantly altered in those with liver impairment, which can lead to increased levels of the drug in the blood.

Drug Interactions

Ranolazine interacts with many other medications, which can increase the risk of side effects or reduce the drug's effectiveness. It should not be used with:

• Strong CYP3A inhibitors, such as certain antifungals (like ketoconazole) or antibiotics (like clarithromycin).
• Strong CYP3A inducers, such as rifampin, St. John's wort, or certain seizure medications (like phenobarbital and phenytoin).

Dose adjustments may be necessary when taken with moderate CYP3A inhibitors like diltiazem or verapamil. Additionally, the dose of simvastatin should be limited to 20 mg daily when taken concurrently with ranolazine.

Dizziness and Syncope

Ranolazine may cause dizziness, lightheadedness, or fainting (syncope). Individuals should be aware of how the medication affects them before performing tasks that require alertness, such as driving.

Pregnancy

There are no adequate and well-controlled studies evaluating the use of ranolazine in pregnant women. While animal studies did not show evidence of harm to the fetus at doses exceeding the maximum human dose, these results do not always predict how a human pregnancy will be affected. Ranolazine should only be used during pregnancy if the potential benefit to the patient outweighs the potential risk to the fetus.

If you are pregnant or planning to become pregnant, talk to your healthcare provider about your treatment options.

Breastfeeding

It is not known whether ranolazine passes into human breast milk. Because of the potential for serious adverse reactions in a nursing infant, healthcare providers typically recommend deciding whether to stop breastfeeding or stop taking the medication. You should consult with your doctor to determine the best course of action based on the importance of the drug to your health.

Dosage Forms

Ranolazine is provided as an extended-release tablet for oral use. This formulation allows the medication to be absorbed gradually by the body.

• Extended-release tablets: These tablets are designed to be swallowed whole. They should not be crushed, chewed, or broken, as doing so can cause the entire dose to be released at once.

FDA Approval and Indications

Ranolazine was approved by the U.S. Food and Drug Administration (FDA) for the treatment of chronic angina. It is intended for long-term management rather than the immediate relief of an acute angina attack. It can be prescribed as a standalone treatment or alongside other heart medications, including beta-blockers, nitrates, and calcium channel blockers.

Regulatory Safety Communications

The FDA has issued safety communications regarding potential drug interactions with ranolazine. Specifically, there are dose limitations when ranolazine is used concurrently with simvastatin due to an increased risk of muscle toxicity. The FDA also identified potential signals of serious risks related to drug-drug interactions in safety reports, leading to updated labeling information.

Contraindications and Restrictions

The FDA-approved labeling includes specific contraindications for use. Ranolazine should not be used by patients with liver cirrhosis. Additionally, it is contraindicated for use with strong CYP3A inhibitors and strong CYP3A inducers, as these can significantly alter the levels of the drug in the body.

Generic vs. Brand Name

Ranolazine is available as a generic medication and under the brand name Ranexa. Generic versions are typically much less expensive than the brand-name equivalent. Choosing the generic form is one of the most common ways to reduce the cost of this treatment.

Insurance and Medicare Coverage

Most health insurance plans and Medicare Part D cover the generic version of ranolazine. However, the out-of-pocket cost will vary based on your specific plan's deductible and copay tiers. Brand-name Ranexa may require prior authorization from an insurance provider or may be placed on a higher cost tier.

Factors Affecting Price

• Dosage: Ranolazine is available in 500 mg and 1000 mg extended-release tablets. The strength of the medication can influence the total price.
• Quantity: Buying a 90-day supply through a mail-order pharmacy may be more cost-effective than purchasing a 30-day supply at a retail location.
• Pharmacy Choice: Prices can vary between different retail pharmacies and online services.

Financial Assistance

For patients who are prescribed the brand-name version or who have high out-of-pocket costs, manufacturer coupons or patient assistance programs may be available to help reduce the price. Eligibility for these programs often depends on insurance status and income level.